Stacks Image 666
This information is lifted from Professor McNicholas Blog June 2013 and has been updated to include the NICE assessments of 2014 and 2015.
For patients interested in UroLift

You may have heard of or already inquired about treatment with the UroLift® implant system. Urolift is a minimally invasive alternative to standard surgery for the treatment of urinary symptoms due to an enlarged prostate. The UroLift implants hold the prostatic urethra open without the need for incisions, surgical resection or thermal injury to the prostate.

I was part of the original project group and have advised on the development of this exciting and novel treatment since the project began in 2005. I have been conducting UroLift implantations with the final version of the device for 5 years now, the longest experience outside Australia. We typically perform this as a day case procedure under i.v. sedation and in some cases local anaesthesia.

We have been steadily accruing experience and results and are confident urolift is safe and effective though not all men will be suitable. You may be interested to know that more evidence is now available. Results from a rigorous FDA randomized study of UroLift was published in the prestigious Journal of Urology . This is a welcome addition to non-randomized studies previously published in the British Journal of Urology, European Urology (McNicholas et al 2013), Urology and Journal of Sexual Medicine.

Below are highlights from the results of the randomized study of 206 largely American patients:
• UroLift demonstrated exceptional safety, avoiding the major issues that can occur with standard surgery.
• Patients reported returning to normal lifestyle within an average of 8.6 days.
• UroLift was superior to Control in all measures of urological symptoms.
• Symptoms were reduced by 49% (i.e. 2-3 times that seen with alpha blockers).
• Urinary flow rate was also 50% improved (i.e. 1.5-2 times that seen with alpha blockers).
• There was no incidence of sexual dysfunction associated with UroLift.
• Durability to 1 year was proven and upholds the 2 year durability of a prior study.
• After the comparison study, 80% of Control men elected to then be treated with UroLift.
• Quality of Life improvements showed that men were happy with their improvement.

Please contact us if you wish the opportunity to discuss whether UroLift is a good choice for you. You can also find additional information at

Private patients:
I perform urolift procedures at
Spire Hospital, Harpenden, Herts
Pinehill Hospital, Hitchin, Herts and at
The London Clinic, a major private hospital conveniently situated in central London.
We will be pleased to help you liaise with your medical insurer about costs. Call my secretary on 01462-683814. A "self pay option" is also available.

NHS patients: 
Urolift was until recently not available on the NHS outside a trial ( BPH-6). NICE approved urolift as safe for use in early 2014 and in Sept 2015 went further and recommended it for use in the NHS as being not only effective but cost effective so it “could save the NHS money” and should be available.
Even so, local NHS purchasers may delay any decision on purchasing Urolift due to current cost pressures on the NHS. NHS Urolift may become increasingly available. Currently Central Middx, Charing Cross and Kings College Hospitals in London are offering UroLift to their patients.

N.I.C.E. now provide guidance for Insertion of prostatic urethral lift implants to treat lower urinary tract symptoms secondary to benign prostatic hyperplasia Link to NICE web site

Stacks Image 768